SILEVERTINIB

UNII:	RP9F537KVY
Formula:	C₃₀H₃₀ClFN₆O₂
Preferred Substance Name:	SILEVERTINIB
InChIKey:	LMOVDLRMIRLIJF-TUVXKDNKSA-N
GSRS Full Record:	RP9F537KVY i

2607829-38-7
(2E)-N-(4-((3-CHLORO-2-FLUOROPHENYL)AMINO)-7-(2-((1R,5S)-3-METHYL-3-AZABICYCLO(3.1.0)HEX-1-YL)ETHYNYL)-6-QUINAZOLINYL)-4-(4-MORPHOLINYL)-2-BUTENAMIDE
(E)-N-(4-((3-CHLORO-2-FLUOROPHENYL)AMINO)-7-(((1R,5S)-3-METHYL-3-AZABICYCLO(3.1.0)HEXAN-1-YL)ETHYNYL)QUINAZOLIN-6-YL)-4-MORPHOLINOBUT-2-ENAMIDE
-2-BUTENAMIDE, N-(4-((3-CHLORO-2-FLUOROPHENYL)AMINO)-7-(2-((1R,5S)-3-METHYL-3-AZABICYCLO(3.1.0)HEX-1-YL)ETHYNYL)-6-QUINAZOLINYL)-4-(4-MORPHOLINYL)-, (2E)-
BDTX-1535
EGFR-IN-76
SILEVERTINIB [INN]
SILEVERTINIB [USAN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SILEVERTINIB

Synonyms and Mappings

Resources